Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney Disease
Authors:
- 1 June 2022
- journal article
- research article
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 23 (6) , 998-1004.e7
Abstract
No abstract availableKeywords
Funding Information
- Merck Sharp and Dohme Chibret
- GlaxoSmithKline
- Agence Nationale de la Recherche
- Baxter International Inc
- Otsuka Pharmaceutical Co Ltd
- Amgen
- Lilly Endowment Inc
- Fresenius Medical Care North America
This publication has 39 references indexed in Scilit:
- Epidemiology and prognostic significance of chronic kidney disease in the elderly—the Three-City prospective cohort studyNephrology Dialysis Transplantation, 2011
- The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: A 3-year, randomized, multicenter, double-blind, placebo-controlled studyClinical Therapeutics, 2008
- Age Affects Outcomes in Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2007
- Efficacy and Safety of Angiotensin II Receptor Blockade in Elderly Patients With DiabetesDiabetes Care, 2006
- Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) TrialCirculation, 2006
- Efficacy and Safety of Benazepril for Advanced Chronic Renal InsufficiencyNew England Journal of Medicine, 2006
- Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaThe Lancet, 1999
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969
- Studies of Illness in the AgedJAMA, 1963